Cerebral amyloid angiopathy in the elderly

Annals of Neurology

Volumn 70, Issue 6, 2011, Pages 871-880

  Viswanathan, Anand ^a   Greenberg, Steven M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN INJURY; CEREBROSPINAL FLUID; HUMAN; IMAGE ANALYSIS; IMMUNOTHERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; BLOOD VESSELS; BRAIN; BRAIN INJURIES; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; COGNITION DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; PLAQUE, AMYLOID;

EID: 81555196710     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22516     Document Type: Article

References (141)

1. Smith EE, Greenberg SM,. Beta-amyloid, blood vessels, and brain function. Stroke 2009; 40: 2601-2606.
2. Viswanathan A, Greenberg SM,. Chapter 38: Intracerebral hemorrhage. Handb Clin Neurol 2008; 93: 767-790.
3. Vinters HV,. Cerebral amyloid angiopathy. A critical review. Stroke 1987; 18: 311-324. (Pubitemid 17059655)
4. Jellinger KA,. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002; 109: 813-836. (Pubitemid 34810776)
5. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology 1996; 46: 1592-1596. (Pubitemid 26185777)
6. Herzig MC, Winkler DT, Burgermeister P, et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 2004; 7: 954-960. (Pubitemid 39129504)
7. Bell RD, Deane R, Chow N, et al. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 2009; 11: 143-153.
8. Chow N, Bell RD, Deane R, et al. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc Natl Acad Sci U S A 2007; 104: 823-828. (Pubitemid 46154695)
9. Herzig MC, Van Nostrand WE, Jucker M,. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 2006; 16: 40-54.
10. Davis J, Xu F, Deane R, et al. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 2004; 279: 20296-20306. (Pubitemid 38623475)
11. Deane R, Wu Z, Sagare A, et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 2004; 43: 333-344. (Pubitemid 39061126)
12. Monro OR, Mackic JB, Yamada S, et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging 2002; 23: 405-412. (Pubitemid 34312024)
13. Deane R, Du Yan S, Submamaryan RK, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003; 9: 907-913. (Pubitemid 36889934)
14. Eisele YS, Obermuller U, Heilbronner G, et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 2010; 330: 980-982.
15. Sutcliffe JG, Hedlund PB, Thomas EA, et al. Peripheral reduction of beta-amyloid is sufficient to reduce brain beta-amyloid: implications for Alzheimer's disease. J Neurosci Res 2011; 89: 808-814.
16. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA,. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 2003; 10: 463-470. (Pubitemid 39004272)
17. Mackic JB, Bading J, Ghiso J, et al. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vascul Pharmacol 2002; 38: 303-313. (Pubitemid 36398252)
18. Mackic JB, Weiss MH, Miao W, et al. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy. J Neurochem 1998; 70: 210-215. (Pubitemid 28020845)
19. Poduslo JF, Curran GL, Haggard JJ, et al. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier. Neurobiol Dis 1997; 4: 27-34. (Pubitemid 27509275)
20. Martel CL, Mackic JB, McComb JG, et al. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs. Neurosci Lett 1996; 206: 157-160. (Pubitemid 26096445)
21. Ghilardi JR, Catton M, Stimson ER, et al. Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo. Neuroreport 1996; 7: 2607-2611. (Pubitemid 26403025)
22. Zlokovic BV, Ghiso J, Mackic JB, et al. Blood-brain barrier transport of circulating Alzheimer's amyloid beta. Biochem Biophys Res Commun 1993; 197: 1034-1040. (Pubitemid 24042727)
23. Grabowski TJ, Cho HS, Vonsattel JP, et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001; 49: 697-705. (Pubitemid 32530235)
24. Mandybur TI,. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986; 45: 79-90. (Pubitemid 16189845)
25. Vinters HV, Natte R, Maat-Schieman ML, et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol 1998; 95: 235-244. (Pubitemid 28120668)
26. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991; 30: 637-649.
27. Zekry D, Duyckaerts C, Belmin J, et al. Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia. Acta Neuropathol 2003; 106: 367-373. (Pubitemid 37265317)
28. Vinters HV, Secor DL, Read SL, et al. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 1994; 18: 333-348. (Pubitemid 24184171)
29. Calhoun ME, Burgermeister P, Phinney AL, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A 1999; 96: 14088-14093.
30. Christie R, Yamada M, Moskowitz M, Hyman B,. Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 2001; 158: 1065-1071. (Pubitemid 32221798)
31. Fryer JD, Taylor JW, DeMattos RB, et al. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J Neurosci 2003; 23: 7889-7896. (Pubitemid 37052357)
32. Van Dorpe J, Smeijers L, Dewachter I, et al. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 2000; 157: 1283-1298.
33. Winkler DT, Bondolfi L, Herzig MC, et al. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 2001; 21: 1619-1627. (Pubitemid 32182202)
34. Kimchi EY, Kajdasz S, Bacskai BJ, Hyman BT,. Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy. J Neuropathol Exp Neurol 2001; 60: 274-279. (Pubitemid 32209646)
35. Niwa K, Carlson GA, Iadecola C,. Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab 2000; 20: 1659-1668.
36. Niwa K, Younkin L, Ebeling C, et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A 2000; 97: 9735-9740. (Pubitemid 30650845)
37. Han BH, Zhou ML, Abousaleh F, et al. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. J Neurosci 2008; 28: 13542-13550.
38. Shin HK, Jones PB, Garcia-Alloza M, et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 2007; 130: 2310-2319. (Pubitemid 47327629)
39. Natte R, Maat-Schieman ML, Haan J, et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001; 50: 765-772. (Pubitemid 33116136)
40. Thal DR, Capetillo-Zarate E, Larionov S, et al. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol Aging 2009; 30: 1936-1948.
41. Smith EE, Vijayappa M, Lima F, et al. Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology 2008; 71: 1424-1430.
42. Viswanathan A, Patel P, Rahman R, et al. Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke 2008; 39: 1988-1992.
43. Smith EE, Gurol ME, Eng JA, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 2004; 63: 1606-1612. (Pubitemid 39507576)
44. Holland CM, Smith EE, Csapo I, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke 2008; 39: 1127-1133. (Pubitemid 351440680)
45. Gurol ME, Irizarry MC, Smith EE, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006; 66: 23-29. (Pubitemid 43739586)
46. Smith EE, Nandigam KR, Chen YW, et al. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke 2010; 41: 1933-1938.
47. Zhu Y, Chabriat H, Godin O, et al. Distribution of white matter hyperintensity in patients with intracerebral hemorrhage and healthy aging. Paper presented at: Second International CAA Conference: Cerebral Amyloid Angiopathy and Related Microangiopathies; May 13-15, 2010; Los Angeles, CA.
48. Olichney JM, Hansen LA, Hofstetter CR, et al. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol 2000; 57: 869-874. (Pubitemid 30397190)
49. Haglund M, Passant U, Sjobeck M, et al. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 2006; 21: 681-687. (Pubitemid 44122077)
50. Suter OC, Sunthorn T, Kraftsik R, et al. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002; 33: 1986-1992. (Pubitemid 34840055)
51. Okamoto Y, Ihara M, Fujita Y, et al. Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia. Neuroreport 2009; 20: 990-996.
52. Okazaki H, Reagan TJ, Campbell RJ,. Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979; 54: 22-31. (Pubitemid 9116377)
53. Soontornniyomkij V, Lynch MD, Mermash S, et al. Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol 2010; 20: 459-467.
54. Kimberly WT, Gilson A, Rost NS, et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009; 72: 1230-1235.
55. Menon RS, Kidwell CS,. Neuroimaging demonstration of evolving small vessel ischemic injury in cerebral amyloid angiopathy. Stroke 2009; 40: e675-e677.
56. Lansberg MG, Thijs VN, O'Brien MW, et al. Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. AJNR Am J Neuroradiol 2001; 22: 637-644. (Pubitemid 32318688)
57. Greenberg SM, Eng JA, Ning M, et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004; 35: 1415-1420. (Pubitemid 38697468)
58. Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, et al. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol 2006; 16: 30-39.
59. Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002; 33: 1190-1195. (Pubitemid 34517033)
60. Biffi A, Ayres AM, Sonni A, et al. APOE Genotype Predicts Hematoma Volume and Expansion in Intracerebral Hemorrhage. Paper presented at: International Stroke Conference; February 9-11, 2011; Los Angeles, CA.
61. Biffi A, Sonni A, Anderson CD, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 2010; 68: 934-943.
62. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000; 342: 240-245. (Pubitemid 30058955)
63. Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998; 50: 961-965. (Pubitemid 28212822)
64. Greenberg SM, Briggs ME, Hyman BT, et al. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996; 27: 1333-1337. (Pubitemid 26286163)
65. McCarron MO, Nicoll JA, Stewart J, et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 1999; 58: 711-718. (Pubitemid 29328500)
66. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993; 90: 9649-9653. (Pubitemid 23315843)
67. Premkumar DR, Cohen DL, Hedera P, et al. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996; 148: 2083-2095.
68. Greenberg SM, Rebeck GW, Vonsattel JP, et al. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995; 38: 254-259.
69. Corder EH, Lannfelt L, Bogdanovic N, et al. The role of APOE polymorphisms in late-onset dementias. Cell Mol Life Sci 1998; 54: 928-934. (Pubitemid 28461682)
70. Saunders AM, Hulette O, Welsh-Bohmer KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996; 348: 90-93. (Pubitemid 26234356)
71. Verghese PB, Castellano JM, Holtzman DM,. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011; 10: 241-252.
72. Scharf J, Brauherr E, Forsting M, Sartor K,. Significance of haemorrhagic lacunes on MRI in patients with hypertensive cerebrovascular disease and intracerebral haemorrhage. Neuroradiology 1994; 36: 504-508. (Pubitemid 24316497)
73. Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996; 17: 573-578. (Pubitemid 26101967)
74. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999; 20: 637-642. (Pubitemid 30429021)
75. Ripoll MA, Siosteen B, Hartman M, Raininko R,. MR detectability and appearance of small experimental intracranial hematomas at 1.5 T and 0.5 T. A 6-7-month follow-up study. Acta Radiol 2003; 44: 199-205.
76. Alemany Ripoll M, Stenborg A, Sonninen P, et al. Detection and appearance of intraparenchymal haematomas of the brain at 1.5 T with spin-echo, FLAIR and GE sequences: poor relationship to the age of the haematoma. Neuroradiology 2004; 46: 435-443. (Pubitemid 39004408)
77. Atlas SW, Mark AS, Grossman RI, Gomori JM,. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology 1988; 168: 803-807.
78. Greenberg SM, Finklestein SP, Schaefer PW,. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology 1996; 46: 1751-1754. (Pubitemid 26185809)
79. Roob G, Fazekas F,. Magnetic resonance imaging of cerebral microbleeds. Curr Opin Neurol 2000; 13: 69-73.
80. Haacke EM, DelProposto ZS, Chaturvedi S, et al. Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. AJNR Am J Neuroradiol 2007; 28: 316-317. (Pubitemid 46281054)
81. Nandigam K, Viswanathan A, Skehan ME, et al. Newer susceptibility- weighted MRI to detect cerebral microbleeds: examining the effect of field strength, sequence parameters, and slice thickness. A JNR Am J Neuroractology 2009; 30: 338-343.
82. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008; 70: 1208-1214. (Pubitemid 351482572)
83. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8: 165-174.
84. Knudsen KA, Rosand J, Karluk D, Greenberg SM,. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001; 56: 537-539. (Pubitemid 32172884)
85. Greenberg SM, O'Donnell HC, Schaefer PW, Kraft E,. MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 1999; 53: 1135-1138. (Pubitemid 29442140)
86. Vinters HV, Gilbert JJ,. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983; 14: 924-928. (Pubitemid 14205243)
87. Ropper AH, Davis KR,. Lobar cerebral hemorrhages: acute clinical syndromes in 26 cases. Ann Neurol 1980; 8: 141-147. (Pubitemid 11238302)
88. Kase CS,. Lobar hemorrhage. In:, Kase CS, Caplan LR, eds. Intracerebral hemorrhage. Boston, MA: Butterworth-Heinemann, 1994: 363-382.
89. Rosand J, Muzikansky A, Kumar A, et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 2005; 58: 459-462. (Pubitemid 41266633)
90. Greenberg SM, Nandigam RN, Delgado P, et al. Microbleeds versus macrobleeds: evidence for distinct entities. Stroke 2009; 40: 2382-2386.
91. Okoye MI, Watanabe I,. Ultrastructural features of cerebral amyloid angiopathy. Hum Pathol 1982; 13: 1127-1132. (Pubitemid 13177475)
92. Atri A, Locascio JJ, Lin JM, et al. Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis 2005; 2: 305-312.
93. Cordonnier C, van der Flier WM, Sluimer JD, et al. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006; 66: 1356-1360. (Pubitemid 43739644)
94. Hanyu H, Tanaka Y, Shimizu S, et al. Cerebral microbleeds in Alzheimer's disease. J Neurol 2003; 250: 1496-1497.
95. Nakata Y, Shiga K, Yoshikawa K, et al. Subclinical brain hemorrhages in Alzheimer's disease: evaluation by magnetic resonance T2*-weighted images. Ann N Y Acad Sci 2002; 977: 169-172. (Pubitemid 35418151)
96. Pettersen JA, Sathiyamoorthy G, Gao F-Q, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol 2008; 65: 790-795. (Pubitemid 351831457)
97. Cordonnier C, Al-Shahi Salman R, Wardlaw J,. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007; 130: 1988-2003. (Pubitemid 47236609)
98. Viswanathan A, Chabriat H,. Cerebral microhemorrhage. Stroke 2006; 37: 550-555. (Pubitemid 43732025)
99. Petrovitch H, Ross GW, Steinhorn SC, et al. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 2005; 57: 98-103. (Pubitemid 40053320)
100. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277: 813-817. (Pubitemid 27111317)
101. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-175.
102. Pfeifer LA, White LR, Ross GW, et al. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 2002; 58: 1629-1634. (Pubitemid 34602893)
103. Esiri MM, Nagy Z, Smith MZ, et al. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999; 354: 919-920. (Pubitemid 29424028)
104. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998; 51: 159-162. (Pubitemid 28345377)
105. Esiri MM, Wilcock GK, Morris JH,. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997; 63: 749-753. (Pubitemid 27520751)
106. Lee JH, Olichney JM, Hansen LA, et al. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol 2000; 57: 1474-1479.
107. Zekry D, Duyckaerts C, Moulias R, et al. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol 2002; 103: 481-487. (Pubitemid 36075344)
108. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222. (Pubitemid 36359297)
109. Longstreth WT Jr, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2002; 33: 2376-2382.
110. Orgogozo JM, Gilman S, Dartigues JF, et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003; 61: 46-54. (Pubitemid 36818745)
111. Ferrer I, Boada Rovira M, Sanchez Guerra ML, et al. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol 2004; 14: 11-20. (Pubitemid 38200585)
112. Nicoll JA, Wilkinson D, Holmes C, et al. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 2003; 9: 448-452. (Pubitemid 36460079)
113. Eng JA, Frosch MP, Choi K, et al. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004; 55: 250-256. (Pubitemid 38167002)
114. Kinnecom C, Lev MH, Wendell L, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007; 68: 1411-1416. (Pubitemid 46661556)
115. Black RS, Sperling R, Kirby L, et al. A single ascending dose study of bapinezumab, a humanized monoclonal antibody to A″, in AD. 2006. Paper presented at: Ninth Annual Geneva Springfield Symposium on Advances in Alzheimer's Therapy; April 19-22, 2006; Geneva, Switzerland.
116. Sveinbjornsdottir S, Sigurdsson S, Aspelund T, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry 2008; 79: 1002-1006.
117. Arvanitakis Z, Leurgans S, Wang Z, et al. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 2011; 69: 320-327.
118. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004; 55: 306-319. (Pubitemid 38269583)
119. Bacskai BJ, Hickey GA, Skoch J, et al. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc Natl Acad Sci U S A 2003; 100: 12462-12467. (Pubitemid 37271582)
120. Bacskai BJ, Frosch MP, Freeman SH, et al. Molecular imaging with Pittsburgh compound B confirmed at autopsy: a case report. Arch Neurol 2007; 64: 431-434. (Pubitemid 46425701)
121. Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 2007; 62: 229-234. (Pubitemid 47525398)
122. Ly JV, Donnan GA, Villemagne VL, et al. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology 2010; 74: 487-493.
123. Greenberg SM, Grabowski T, Gurol ME, et al. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol 2008; 64: 587-591.
124. De Meyer G, Shapiro F, Vanderstichele H, et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol 2010; 67: 949-956.
125. Vemuri P, Wiste HJ, Weigand SD, et al. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol 2010; 67: 308-316.
126. Vemuri P, Wiste HJ, Weigand SD, et al. Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 2010; 75: 143-151.
127. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746. (Pubitemid 47058377)
128. de Jong D, Kremer BP, Olde Rikkert MG, Verbeek MM,. Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin Chem Lab Med 2007; 45: 1421-1434. (Pubitemid 350036575)
129. Hulstaert F, Blennow K, Ivanoiu A, et al. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology 1999; 52: 1555-1562. (Pubitemid 29220627)
130. Verbeek MM, De Jong D, Kremer HP,. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Ann Clin Biochem 2003; 40: 25-40. (Pubitemid 36051407)
131. Sunderland T, Linker G, Mirza N, et al. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 2003; 289: 2094-2103. (Pubitemid 37430211)
132. Verbeek MM, Kremer BP, Rikkert MO, et al. Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol 2009; 66: 245-249.
133. Salat DH, Smith EE, Tuch DS, et al. White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging. Stroke 2006; 37: 1759-1764. (Pubitemid 44297726)
134. Arima H, Tzourio C, Anderson C, et al. Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke 2010; 41: 394-396.
135. Eckman MH, Rosand J, Knudsen KA, et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003; 34: 1710-1716. (Pubitemid 36842632)
136. Lee SH, Ryu WS, Roh JK,. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology 2009; 72: 171-176.
137. Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol 2008; 255: 1679-1686.
138. Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010; 75: 693-698.
139. Prada CM, Garcia-Alloza M, Betensky RA, et al. Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci 2007; 27: 1973-1980.
140. Schroeter S, Khan K, Barbour R, et al. Immunotherapy reduces vascular amyloid-beta in PDAPP mice. J Neurosci 2008; 28: 6787-6793.
141. Thakker DR, Weatherspoon MR, Harrison J, et al. Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice. Proc Natl Acad Sci U S A 2009; 106: 4501-4506.